ALK and laryngotracheoesophageal cleft: In LC, several driver genes involved in tumor progression also contribute to immune escape, including Kirsten rat sarcoma virus oncogene homolog (KRAS), epidermal growth factor receptors (EGFRs), and anaplastic lymphoma kinase (ALK) [42,43].